The Use of Cognitive Screening in Pharmacotherapy Trials for Cognitive Impairment Associated With Schizophrenia

Autor: Jack Cotter, Jennifer H. Barnett, Kiri Granger

Publikováno v: Frontiers in Psychiatry, Vol 10 (2019)

There are currently no regulatory approved pharmacological treatments for cognitive impairment associated with schizophrenia (CIAS). One possibility is that trial methodology itself is hindering their development. Emerging evidence suggests that pati

Externí odkaz: https://doaj.org/article/a65ea29b483a489db768a4ea5782d363

Emotional bias training as a treatment for anxiety and depression: evidence from experimental medicine studies in healthy and medicated samples

Autor: Ian S. Penton-Voak, Marcus R. Munafò, Maren Müller-Glodde, Steph Suddell, Jim Lumsden, Chung Yen Looi, Kiri Granger, Oliver J. Robinson, Jennifer H. Barnett

Publikováno v: Suddell, S, Muller-Glodde, M, Lumsden, J A, Looi, C, Granger, K, Barnett, J H, Robinson, O, Munafo, M R & Penton-Voak, I S 2021, ' Emotional bias training as a treatment for anxiety and depression : evidence from experimental medicine studies in healthy and medicated samples ', Psychological Medicine . https://doi.org/10.1017/S0033291721002014

BackgroundAnxiety and depression are leading causes of disability worldwide, yet individuals are often unable to access appropriate treatment. There is a need to develop effective interventions that can be delivered remotely. Previous research has su

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8d8691f224dbb961017c3d6f4c52485
https://pubmed.ncbi.nlm.nih.gov/34057058

Validation and Comparison of a Digital Digit Symbol Substitution (DSST) Task Performed on Smart Phones With a Traditional Paper-Pencil Version

Autor: Luke Allen, Emily Thorp, Jenny Barnett, Nathan Cashdollar, Kiri Granger, Daniel Thorpe, Miriam Evans, Francesca Cormack, Elizabeth A. Baker

Publikováno v: Biological Psychiatry. 89:S132-S133

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::925c8ede77f48d046ce6f11b4dae9271
https://doi.org/10.1016/j.biopsych.2021.02.342

O10.4. LATENT INHIBITION AS A STRATIFICATION TOOL FOR SCHIZOPHRENIA DRUG DEVELOPMENT

Autor: Kiri Granger, Jennifer Ferrar, Carlos Sillero Rejon, Jennifer H. Barnett, Marcus R. Munafò, Angela Atwood

BACKGROUND: Stratified medicine approaches have potential to dramatically improve the efficacy of drug development for schizophrenia and other psychiatric conditions, as they have for cancer. Such methods require accurate biomarkers that define popul

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f440c0b97683c3c14b72d92a342e083
https://europepmc.org/articles/PMC6455479/

Social cognitive dysfunction as a clinical marker:A systematic review of meta-analyses across 30 clinical conditions

Autor: Jennifer H. Barnett, Rosa Backx, Jack Cotter, Kiri Granger, Chung Yen Looi, Matthew Hobbs

Publikováno v: Cotter, J, Granger, K, Backx, R, Hobbs, M, Looi, C Y & Barnett, J H 2018, ' Social cognitive dysfunction as a clinical marker : A systematic review of meta-analyses across 30 clinical conditions ', Neuroscience and Biobehavioral Reviews, vol. 84, pp. 92-99 . https://doi.org/10.1016/j.neubiorev.2017.11.014, https://doi.org/10.1016/j.neubiorev.2017.11.014

Social cognition includes a range of cognitive processes that help individuals to understand how others think and feel. There is emerging evidence that social cognitive deficits may represent a transdiagnostic issue, potentially serving as a marker o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51a4ba8519097dfc667531b05c763637
http://www.scopus.com/inward/record.url?scp=85035754020&partnerID=8YFLogxK